BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21818385)

  • 1. Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells.
    Bacher N; Graulich E; Jonuleit H; Grabbe S; Steinbrink K
    PLoS One; 2011; 6(7):e22763. PubMed ID: 21818385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion.
    Eljaafari A; Li YP; Miossec P
    J Immunol; 2009 Sep; 183(5):2932-45. PubMed ID: 19696431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.
    Rossetti M; Gregori S; Roncarolo MG
    Eur J Immunol; 2010 Nov; 40(11):3097-106. PubMed ID: 20957751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.
    Pellerin L; Chen P; Gregori S; Hernandez-Hoyos G; Bacchetta R; Roncarolo MG
    Front Immunol; 2018; 9():881. PubMed ID: 29887861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.
    Unger WW; Laban S; Kleijwegt FS; van der Slik AR; Roep BO
    Eur J Immunol; 2009 Nov; 39(11):3147-59. PubMed ID: 19688742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
    Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
    J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human invariant Valpha24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells.
    Yamaura A; Hotta C; Nakazawa M; Van Kaer L; Minami M
    Blood; 2008 Apr; 111(8):4254-63. PubMed ID: 18270329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.
    Leplina O; Kurochkina Y; Tikhonova M; Shevela E; Ostanin A; Chernykh E
    Inflammopharmacology; 2020 Feb; 28(1):311-319. PubMed ID: 31552546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells.
    Tuettenberg A; Huter E; Hubo M; Horn J; Knop J; Grimbacher B; Kroczek RA; Stoll S; Jonuleit H
    J Immunol; 2009 Mar; 182(6):3349-56. PubMed ID: 19265111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic Activity.
    Kryczanowsky F; Raker V; Graulich E; Domogalla MP; Steinbrink K
    J Immunol; 2016 Nov; 197(9):3607-3617. PubMed ID: 27683749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.
    Steinbrink K; Jonuleit H; Müller G; Schuler G; Knop J; Enk AH
    Blood; 1999 Mar; 93(5):1634-42. PubMed ID: 10029592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro].
    Tang JF; Guan SH; Wang ZG
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of clinical grade human tolerogenic dendritic cells.
    Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
    J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
    Grohmann U; Fallarino F; Bianchi R; Belladonna ML; Vacca C; Orabona C; Uyttenhove C; Fioretti MC; Puccetti P
    J Immunol; 2001 Jul; 167(2):708-14. PubMed ID: 11441074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research in practice: the impact of interferon-α therapy on immune tolerance.
    Raker V; Steinbrink K
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):315-9. PubMed ID: 24628847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
    Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
    Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.